Form 8-K - Current report:
SEC Accession No. 0001493152-22-011560
Filing Date
2022-04-29
Accepted
2022-04-29 16:07:06
Documents
13
Period of Report
2022-04-25
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38953
2 e3-1.htm EX-3.1 9948
  Complete submission text file 0001493152-22-011560.txt   226878

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abeo-20220425.xsd EX-101.SCH 3063
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abeo-20220425_lab.xml EX-101.LAB 34476
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abeo-20220425_pre.xml EX-101.PRE 22615
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3724
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 22875271
SIC: 2834 Pharmaceutical Preparations